|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 478,500.00 KRW | -2.25% |
|
+2.03% | +61.38% |
| 09:53pm | South Korean shares hit six-week high on hopes of US-Iran deal | RE |
| 04-13 | South Korean shares decline as investors assess Iran war risks | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 1.88 | 2.51 | 3.51 | 2.86 | 2.02 | |||||
Return on Total Capital | 2.32 | 3.1 | 4.38 | 3.52 | 2.46 | |||||
Return On Equity % | 7.16 | 9.2 | 13.48 | 12.2 | 8.36 | |||||
Return on Common Equity | 6.86 | 9.39 | 14.54 | 12.77 | 8.43 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 18.65 | 19.87 | 20.58 | 20.4 | 18.37 | |||||
SG&A Margin | 11.66 | 11.74 | 9.96 | 10.92 | 10.75 | |||||
EBITDA Margin % | 8.22 | 9.18 | 11.35 | 9.92 | 8.03 | |||||
EBITA Margin % | 5.72 | 6.95 | 9.33 | 8.16 | 6.21 | |||||
EBIT Margin % | 5.68 | 6.89 | 9.3 | 8.13 | 6.16 | |||||
Income From Continuing Operations Margin % | 4.84 | 5.6 | 7.99 | 7.73 | 5.56 | |||||
Net Income Margin % | 4.2 | 5.17 | 7.35 | 7.15 | 5.07 | |||||
Net Avail. For Common Margin % | 4.2 | 5.17 | 7.8 | 7.33 | 5.07 | |||||
Normalized Net Income Margin | 3.61 | 4.42 | 6.66 | 5.98 | 4.18 | |||||
Levered Free Cash Flow Margin | 1 | 2.7 | -0.54 | -3.37 | -3.87 | |||||
Unlevered Free Cash Flow Margin | 1.16 | 2.94 | -0.32 | -3.21 | -3.68 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.53 | 0.58 | 0.6 | 0.56 | 0.53 | |||||
Fixed Assets Turnover | 1.99 | 2.23 | 2.42 | 2.21 | 1.93 | |||||
Receivables Turnover (Average Receivables) | 23.3 | 25.1 | 25.43 | 24.67 | 20.07 | |||||
Inventory Turnover (Average Inventory) | 8.33 | 8.81 | 8.15 | 7.5 | 7.52 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.38 | 1.3 | 1.39 | 1.46 | 1.36 | |||||
Quick Ratio | 1.17 | 1.07 | 1.11 | 1.16 | 1.09 | |||||
Operating Cash Flow to Current Liabilities | -0.02 | 0.14 | -0.03 | -0.07 | -0.07 | |||||
Days Sales Outstanding (Average Receivables) | 15.66 | 14.54 | 14.35 | 14.84 | 18.19 | |||||
Days Outstanding Inventory (Average Inventory) | 43.83 | 41.45 | 44.77 | 48.79 | 48.56 | |||||
Average Days Payable Outstanding | 34.12 | 31.16 | 30 | 30.31 | 29.64 | |||||
Cash Conversion Cycle (Average Days) | 25.37 | 24.83 | 29.12 | 33.32 | 37.1 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 131.63 | 124.64 | 123.57 | 131.16 | 138.28 | |||||
Total Debt / Total Capital | 56.83 | 55.48 | 55.27 | 56.74 | 58.03 | |||||
LT Debt/Equity | 90.67 | 83.56 | 89.81 | 100.94 | 103.42 | |||||
Long-Term Debt / Total Capital | 39.15 | 37.2 | 40.17 | 43.67 | 43.4 | |||||
Total Liabilities / Total Assets | 64.69 | 64.46 | 63.96 | 64.6 | 65.39 | |||||
EBIT / Interest Expense | 21.93 | 18.32 | 27.13 | 31.54 | 20.04 | |||||
EBITDA / Interest Expense | 32.41 | 24.4 | 33.59 | 39.21 | 26.77 | |||||
(EBITDA - Capex) / Interest Expense | 18.28 | 16.91 | 20.91 | 21.35 | 12.14 | |||||
Total Debt / EBITDA | 11.02 | 8.66 | 6.72 | 8.91 | 11.52 | |||||
Net Debt / EBITDA | 7.77 | 6.21 | 5.17 | 7.2 | 9.8 | |||||
Total Debt / (EBITDA - Capex) | 19.53 | 12.5 | 10.79 | 16.36 | 25.4 | |||||
Net Debt / (EBITDA - Capex) | 13.78 | 8.95 | 8.31 | 13.22 | 21.6 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 13.09 | 21.19 | 14.43 | 7.73 | 6.29 | |||||
Gross Profit, 1 Yr. Growth % | 18.66 | 29.13 | 18.44 | 6.76 | -4.29 | |||||
EBITDA, 1 Yr. Growth % | 86.67 | 35.29 | 41.04 | -4.38 | -13.96 | |||||
EBITA, 1 Yr. Growth % | 176.95 | 47.08 | 53.18 | -5.73 | -19.1 | |||||
EBIT, 1 Yr. Growth % | 178.91 | 47.03 | 53.96 | -5.87 | -19.47 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 195.81 | 40.23 | 58.39 | 4.29 | -23.5 | |||||
Net Income, 1 Yr. Growth % | 246.97 | 49.01 | 62.43 | 4.72 | -24.59 | |||||
Normalized Net Income, 1 Yr. Growth % | 398.58 | 48.47 | 68.09 | -3.26 | -25.72 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 247.11 | 49.83 | 65.25 | 0.74 | -25.74 | |||||
Accounts Receivable, 1 Yr. Growth % | 0.71 | 24.62 | 3.17 | 14.37 | 43.16 | |||||
Inventory, 1 Yr. Growth % | 2.75 | 22.72 | 21.76 | 13.74 | 4.4 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 13.32 | 3.41 | 7.19 | 27.88 | 16.67 | |||||
Total Assets, 1 Yr. Growth % | 11.75 | 9.32 | 10.45 | 20.3 | 8.55 | |||||
Tangible Book Value, 1 Yr. Growth % | 7.52 | 9.07 | 12.35 | 18.38 | 6.06 | |||||
Common Equity, 1 Yr. Growth % | 7.95 | 9.85 | 12.35 | 17.99 | 5.82 | |||||
Cash From Operations, 1 Yr. Growth % | 187.07 | -1K | -123.7 | 124.78 | 5.82 | |||||
Capital Expenditures, 1 Yr. Growth % | -8.18 | -6.72 | 76.11 | 14.01 | 3.79 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 58.04 | 294.73 | -121.36 | 417.74 | 22.16 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 40.79 | 259.04 | -111.86 | 609.87 | 21.93 | |||||
Dividend Per Share, 1 Yr. Growth % | 66.67 | 40 | 62.86 | 5.26 | -16.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.46 | 17.07 | 17.6 | 11.03 | 7.01 | |||||
Gross Profit, 2 Yr. CAGR % | 11.45 | 23.78 | 23.57 | 12.45 | 1.09 | |||||
EBITDA, 2 Yr. CAGR % | 24.93 | 58.91 | 38.16 | 15.28 | -9.3 | |||||
EBITA, 2 Yr. CAGR % | 35.79 | 101.83 | 50.14 | 20.16 | -12.67 | |||||
EBIT, 2 Yr. CAGR % | 36.1 | 102.5 | 50.49 | 20.39 | -12.93 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 33.68 | 103.67 | 51.07 | 28.52 | -10.68 | |||||
Net Income, 2 Yr. CAGR % | 28.78 | 127.38 | 55.57 | 30.42 | -11.14 | |||||
Normalized Net Income, 2 Yr. CAGR % | 30.91 | 172.08 | 59.79 | 27.52 | -15.23 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 29.48 | 128.05 | 59.67 | 29.03 | -13.5 | |||||
Accounts Receivable, 2 Yr. CAGR % | -1.24 | 12.03 | 13.39 | 8.62 | 27.96 | |||||
Inventory, 2 Yr. CAGR % | -0.08 | 12.29 | 22.24 | 17.68 | 8.97 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.22 | 8.25 | 5.28 | 17.08 | 22.15 | |||||
Total Assets, 2 Yr. CAGR % | 9.67 | 10.53 | 9.88 | 15.27 | 14.27 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.09 | 8.29 | 10.7 | 15.33 | 12.05 | |||||
Common Equity, 2 Yr. CAGR % | 3.46 | 8.89 | 11.09 | 15.14 | 11.74 | |||||
Cash From Operations, 2 Yr. CAGR % | 67.4 | 409.24 | 46.32 | -27.01 | 54.23 | |||||
Capital Expenditures, 2 Yr. CAGR % | 9.55 | -7.45 | 28.17 | 41.7 | 8.78 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -23.01 | 127.4 | -5.51 | 20.31 | 151.49 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -12.54 | 107.62 | -33.04 | 12.95 | 194.21 | |||||
Dividend Per Share, 2 Yr. CAGR % | 11.8 | 52.75 | 51 | 30.93 | -6.34 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 6.7 | 10.46 | 16.08 | 14.21 | 9.43 | |||||
Gross Profit, 3 Yr. CAGR % | 13.14 | 17.06 | 21.91 | 17.69 | 6.57 | |||||
EBITDA, 3 Yr. CAGR % | 26.09 | 28.29 | 52.74 | 21.61 | 4.57 | |||||
EBITA, 3 Yr. CAGR % | 39.77 | 39.45 | 84.13 | 28.56 | 5.32 | |||||
EBIT, 3 Yr. CAGR % | 40.23 | 39.65 | 84.86 | 28.71 | 5.29 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 51.26 | 35.83 | 88.99 | 33.51 | 8.11 | |||||
Net Income, 3 Yr. CAGR % | 48.54 | 35.2 | 103.26 | 36.34 | 8.65 | |||||
Normalized Net Income, 3 Yr. CAGR % | 40.15 | 36.52 | 133.49 | 35.17 | 6.5 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 49.79 | 35.94 | 106.84 | 36.95 | 7.33 | |||||
Accounts Receivable, 3 Yr. CAGR % | -0.99 | 6.72 | 8.99 | 13.71 | 19.09 | |||||
Inventory, 3 Yr. CAGR % | 2.82 | 7.01 | 15.36 | 19.34 | 13.07 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 7.21 | 5.94 | 7.9 | 12.33 | 16.94 | |||||
Total Assets, 3 Yr. CAGR % | 9 | 9.55 | 10.5 | 13.25 | 12.98 | |||||
Tangible Book Value, 3 Yr. CAGR % | 3.08 | 5.04 | 9.63 | 13.2 | 12.15 | |||||
Common Equity, 3 Yr. CAGR % | 3.34 | 5.55 | 10.03 | 13.35 | 11.95 | |||||
Cash From Operations, 3 Yr. CAGR % | -32.14 | 193.63 | 83.18 | 68.83 | -17.39 | |||||
Capital Expenditures, 3 Yr. CAGR % | 10.08 | 3.83 | 14.68 | 23.26 | 27.73 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -10.27 | 24.71 | 5.36 | 82.22 | 20.92 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -9.11 | 32.8 | -18.66 | 68.94 | 15.87 | |||||
Dividend Per Share, 3 Yr. CAGR % | 7.72 | 20.51 | 56.05 | 33.89 | 12.62 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.66 | 8.14 | 10.94 | 10.63 | 12.36 | |||||
Gross Profit, 5 Yr. CAGR % | 4.39 | 10.01 | 17.2 | 15.15 | 13.11 | |||||
EBITDA, 5 Yr. CAGR % | 5.5 | 13.73 | 30.79 | 22.93 | 23.63 | |||||
EBITA, 5 Yr. CAGR % | 5.16 | 16.47 | 43.82 | 31.41 | 36.63 | |||||
EBIT, 5 Yr. CAGR % | 5.16 | 16.51 | 44.25 | 31.62 | 36.79 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -0.09 | 11.92 | 51.18 | 33.58 | 40.04 | |||||
Net Income, 5 Yr. CAGR % | -1.78 | 12.8 | 51.31 | 33.27 | 45.99 | |||||
Normalized Net Income, 5 Yr. CAGR % | 0.31 | 19.42 | 47.7 | 33.45 | 55.69 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -1.16 | 13.65 | 53.67 | 33.91 | 45.94 | |||||
Accounts Receivable, 5 Yr. CAGR % | -4.19 | 3.2 | 4.53 | 7.48 | 16.22 | |||||
Inventory, 5 Yr. CAGR % | 2.05 | 6.81 | 10.18 | 11.15 | 12.76 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 4.37 | 5.14 | 6.44 | 10.26 | 13.38 | |||||
Total Assets, 5 Yr. CAGR % | 5.52 | 7.49 | 9.35 | 11.8 | 11.99 | |||||
Tangible Book Value, 5 Yr. CAGR % | 2.11 | 3.3 | 6.06 | 9.04 | 10.59 | |||||
Common Equity, 5 Yr. CAGR % | 2.23 | 3.58 | 6.37 | 9.28 | 10.71 | |||||
Cash From Operations, 5 Yr. CAGR % | 3.37 | 22.06 | -7.72 | 68.26 | 71 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7.7 | 5.62 | 16.99 | 17.58 | 12.28 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 17.48 | 15.59 | -11.77 | 24.35 | 57.47 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 30.89 | 15.08 | -22.09 | 25.75 | 47.82 | |||||
Dividend Per Share, 5 Yr. CAGR % | 4.56 | 11.84 | 23.3 | 24.57 | 27.23 |
- Stock Market
- Equities
- A005380 Stock
- Financials Hyundai Motor Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















